Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glemont Life Sciences is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse range of generic pharmaceutical formulations. The company maintains a strong presence in the respiratory, dermatology, and anti-infective therapeutic segments, providing affordable healthcare solutions primarily to the Indian market. Its flagship product, Glemont-L, is a widely recognized combination therapy for allergic rhinitis and asthma. Glemont Life Sciences operates with a focus on high-quality manufacturing standards and a robust distribution network to ensure product accessibility. The company continues to expand its portfolio with various fixed-dose combinations and single-agent generics to address prevalent chronic and acute conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glemont L.